JAK/STAT SIGNALING AS A MEDIATOR OF RESPONSE TO COMBINATION OF FLT3 AND MEK INHIBITORS IN ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Damnernsawad, Alisa [1 ]
Lerdwattanasombat, Pat [2 ]
Kraikhun, Panssachon [1 ]
Phanochit, Phanuphat [1 ]
Techo, Todsapol [3 ]
Bottomly, Daniel [4 ]
Nechiporuk, Tamilla [5 ]
McWeeney, Shannon [4 ]
Tyner, Jeffrey [5 ]
机构：
[1] Mahidol Univ, Dept Biol, Fac Sci, Bangkok, Thailand
[2] Mahidol Univ, Program Biomed Sci, Fac Sci, Bangkok, Thailand
[3] Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand
[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Bioinformat & Computat Biol, Portland, OR USA
[5] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell Dev & Canc Biol, Portland, OR USA
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2023年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [21] Recent advances in FLT3 inhibitors for acute myeloid leukemia
    Tong, Lexian
    Li, Xuemei
    Hu, Yongzhou
    Liu, Tao
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (10) : 961 - 981
  • [22] Developments and challenges of FLT3 inhibitors in acute myeloid leukemia
    Ge, Shuai-Shuai
    Liu, Song-Bai
    Xue, Sheng-Li
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Will FLT3 inhibitors fulfill their promise in acute myeloid leukemia?
    Pratz, Keith W.
    Luger, Selina M.
    CURRENT OPINION IN HEMATOLOGY, 2014, 21 (02) : 72 - 78
  • [24] FLT3 Inhibitors in Acute Myeloid Leukemia: Increasing Options
    Kadia, Tapan M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (06) : 352 - 355
  • [25] Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia
    Solana-Altabella, Antonio
    Ballesta-Lopez, Octavio
    Megias-Vericat, Juan Eduardo
    Martinez-Cuadron, David
    Montesinos, Pau
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (01) : 1 - 18
  • [26] FLT3 kinase inhibitors in the management of acute myeloid leukemia
    Illmer, Thomas
    Ehninger, Gerhard
    CLINICAL LYMPHOMA & MYELOMA, 2007, 8 : S24 - S34
  • [27] FLT3 inhibitors in acute myeloid leukemia: Current and future
    Thomas, Christan M.
    Campbell, Peter
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (01) : 163 - 171
  • [28] FLT3 inhibitors: clinical potential in acute myeloid leukemia
    Hospital, Marie-Anne
    Green, Alexa S.
    Maciel, Thiago T.
    Moura, Ivan C.
    Leung, Anskar Y.
    Bouscary, Didier
    Tamburini, Jerome
    ONCOTARGETS AND THERAPY, 2017, 10 : 607 - 615
  • [29] Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia
    Sexauer, Amy N.
    Tasian, Sarah K.
    FRONTIERS IN PEDIATRICS, 2017, 5
  • [30] FLT3 Inhibitors in Combination with FLAG-IDA in Relapsed or Refractory Acute Myeloid Leukemia
    Bouligny, Ian
    Murray, Graeme
    Thuy Ho
    Gor, Juhi
    Zacholski, Kyle
    Wages, Nolan
    Grant, Steven
    Maher, Keri
    BLOOD, 2023, 142
12345